logo-loader
Reckitt Benckiser

Reckitt poaches Pepsi's chief commercial officer to be new boss

Laxman Narasimhan will become chief executive of Reckitt at the start of September, replacing Rakesh Kapoor

Reckitt
Reckitt has been trying to revive sales at its health division

Reckitt Benckiser Group PLC (LON:RB.) shares rose on Wednesday following news it has appointed PepsiCo’s chief commercial officer as its chief executive.

Laxman Narasimhan will become chief executive of Reckitt at the start of September, replacing Rakesh Kapoor.

READ: Reckitt 'remains involved' in US probes, sniffs at weak cold and flu season

The consumer goods company, whose brands include Dettol, Nurofen and Durex, announced in January that Kapoor would be stepping down after 32 years at the company, including eight years in the top job.

Kapoor leaves the company after a difficult couple of years, with the firm having been blighted by a cyber attack, criticism over his pay and factory disruption.

Reckitt handed Kapoor a pay package of £15.2mln for 2018, an 70% increase on the previous year.

Challenges facing incoming boss 

Incoming boss Narasimhan joins Reckitt as the company tries to turnaround sales at its health division, which accounts for nearly two-thirds of revenue. The health business posted a 3% rise in underlying sales growth last year, missing its target of up to 5%.

Narasimhan will also have to deal with a US Department of Justice case against a former Reckitt subsidiary accused of using a fraudulent marketing scheme to increase prescription sales of an opioid addition treatment.

Reckitt spun off the subsidiary into a separate company called Indivior in 2014 but it could still have to pay some of the fines the DoJ wants to impose.

At Pepsi, Narasimhan helped lead an “integrated long-term growth strategy” and has been implementing a digital overhaul across the business, Reckitt said.

“Laxman is an outstanding leader who brings wide experience across the consumer goods sector, both operationally at scale, and from his time at McKinsey,” said Reckitt chairman Chris Sinclair.

“He has led complex operational businesses and inspired teams across developed and emerging markets to achieve market-leading performance.”

New CEO to focus on health business turnaround 

Sinclair said the new CEO’s initial priorities will be to focus on delivering outperformance, particularly in the health business unit, and to drive the group’s so-called ‘RB2.0’ strategy.

Commenting on the appointment, Russ Mould, investment director at AJ Bell said: “Given the company’s recent patchy track record, investors may be pleased to see an outsider chosen to lead consumer goods firm Reckitt Benckiser.

“Joining from PepsiCo, Laxman Narasimhan will probably have more leeway than an internal candidate to make bold changes when he takes over from Rakesh Kapoor in September 2019. This might include boosting investment in the business and its brands which has lagged Reckitt’s peers of late.”

In afternoon trading, shares in Reckitt were up 3.6% at 6,627p. The shares have underperformed the MSCI Europe Consumer Staples index this year and are trading at discount to peers including Procter & Gamble and Unilever, according to Capital IQ.

Quick facts: Reckitt Benckiser

Price: £62.61

Market: LSE
Market Cap: £44.41 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CB2 Insights licenses electronic data capture software to UK...

CB2 Insights (CSE:CBII-OTCQB: CBIIF) CEO Prad Sekar joined Steve Darling from Proactive Vancouver to discuss the company doing a deal with MYACCESS Clinics. This will allow CB2’s software to capture comprehensive data sets related to patient health and treatment histories and manage ongoing...

1 day, 17 hours ago

RNS

Directorate Change

3 days, 22 hours ago

Director/PDMR Shareholding

2 weeks, 5 days ago

Directorate Change

2 weeks, 6 days ago

Total Voting Rights

2 weeks, 6 days ago

Director/PDMR Shareholding

3 weeks, 2 days ago

3 min read